Entecavir Intensification for Persistent Hepatitis B Virus (HBV) Viremia in HIV-HBV Infection

Trial Profile

Entecavir Intensification for Persistent Hepatitis B Virus (HBV) Viremia in HIV-HBV Infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 May 2013

At a glance

  • Drugs Entecavir (Primary) ; Emtricitabine; Lamivudine; Tenofovir disoproxil fumarate
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Mar 2010 Results were presented at the 17th Conference on Retroviruses and Opportunistic Infections.
    • 19 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top